The latest update is out from Aptose Biosciences (APS).
On August 15, 2024, the company announced a significant update through a press release, which should not be considered as official filing information under the Securities Exchange Act of 1934. This information is relevant for investors and market watchers but is not formally filed with or incorporated by regulatory financial documents, barring explicit mention in future filings.
See more data about APS stock on TipRanks’ Stock Analysis page.
